Valuation : Amarin Corporation plc

Market Cap 288M 248M 233M 213M 398M 27.18B 399M 2.75B 1.07B 13.95B 1.08B 1.06B 44.93B P/E 2026 *
-195x
P/E 2027 * -227x
Enterprise Value 126M 108M 102M 92.91M 174M 11.86B 174M 1.2B 466M 6.09B 472M 461M 19.6B EV / Sales 2026 *
0.71x
EV / Sales 2027 * 0.64x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-0.58%
1 week-2.43%
Current month-1.80%
1 month-5.35%
3 months-1.23%
6 months-6.26%
Current year-2.33%
1 week 13.52
Extreme 13.5201
14.32
1 month 13.52
Extreme 13.5201
15.24
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
110.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 2024-06-03
Director of Finance/CFO 42 2024-10-22
Compliance Officer 56 2023-11-14
Director TitleAgeSince
Director/Board Member 63 2024-06-03
Director/Board Member 43 2023-02-27
Director/Board Member 67 2023-02-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/1/26 Exercice

Chief Financial Officer

781 0.0002%
7/1/26 Exercice

Chief Operating Officer

9,302 0.0022%
7/1/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%-2.43%-9.31%-35.71% 288M
-1.79%-2.27%+50.90%+89.03% 67.98B
-2.06%-0.18%+41.53%+88.17% 64.94B
-0.31%+6.54%-11.39%+457.82% 27.58B
-3.00%-2.90%+39.40%+9.41% 25.74B
+0.86%+1.65%+0.25%-14.78% 26.06B
-1.46%+0.42%+24.07%-18.70% 20.09B
-2.96%-15.21%+210.71%+370.84% 17.16B
-1.49%-4.88%-0.41%+530.26% 14.92B
-0.20%+8.37%+57.87%+159.50% 14.62B
Average -1.30%-0.01%+40.36%+163.58% 27.94B
Weighted average by Cap. -1.52%+0.17%+42.24%+144.89%

Financials

2026 *2027 *
Net sales 177M 153M 144M 131M 246M 16.75B 246M 1.7B 659M 8.6B 666M 652M 27.69B 177M 152M 143M 131M 245M 16.7B 245M 1.69B 656M 8.57B 664M 650M 27.6B
Net income -26.62M -22.91M -21.55M -19.69M -36.83M -2.51B -36.94M -255M -98.84M -1.29B -99.97M -97.79M -4.15B -18.32M -15.76M -14.83M -13.55M -25.34M -1.73B -25.41M -175M -68.01M -887M -68.79M -67.29M -2.86B
Net Debt -162M -140M -131M -120M -225M -15.32B -225M -1.55B -602M -7.86B -609M -596M -25.32B -175M -150M -142M -129M -242M -16.51B -243M -1.67B -649M -8.47B -657M -642M -27.29B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
26-09-04 $13.63 -0.58% 80,559
26-09-03 $13.71 +0.07% 48,444
26-09-02 $13.70 -1.05% 45,612
26-09-01 $13.85 -0.25% 39,937
26-08-31 $13.88 -0.64% 40,870
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.63USD
Average target price
12.50USD
Spread / Average Target
-8.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock